Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Cardiology
•
Cardiovascular Imaging
Would you favor functional or anatomical assessment for CAD in a patient with intermediate CV risk factors with equivocal or nondiagnostic exercise treadmill testing and normal renal function?
Related Questions
What is the role of MRI in assessing the risk of embolism in patients with persistent left ventricular thrombus following myocardial infarction?
How are you incorporating the newer RCT data suggesting no mortality benefit to indefinite beta-blocker therapy for patients who are several years out from an MI with preserved LVEF and no angina or arrhythmia?
What are some practical ways to incorporate cardiac POCUS in the primary care setting?
How do you consider and approach transition to hospice in a patient with HFrEF who does not appear to tolerate GDMT?
Do you recommend starting a statin in patients above 75 years old with diabetes but no known ASCVD?
Do you prefer TTE, CMR, or cardiac CT for the evaluation of PFOs?
What stress testing modality do you choose to evaluate patients who are unable to exercise and have anomalous coronary arteries?
What class(es) of antihypertensives should be considered next for refractory hypertension in a patient compliant with high doses of Entresto, chlorthalidone, amlodipine, clonidine, and spironolactone if they previously did not have any improvement on beta blocker or hydralazine and work-up for secondary causes were unremarkable?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
How do you approach prescribing statins in patients with an ASCVD <7.5% but have a strong family history and/or elevated LDL (but <190)?